错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Effect of transcutaneous electro-stimulation in postoperative rehabilitation pain treatment in thoracic surgery: a randomized clinical trial

  • Daniel David Álamo-Arce,
  • Daniel López-Fernández,
  • Raquel Medina-Ramírez,
  • Martín Vílchez-Barrera,
  • Pilar Etopa-Bitata,
  • Maria del Pino Quintana-Montesdeoca,
  • Aníbal Báez-Suárez,
  • Jorge L. Freixinet

摘要

Background

Chest pain is one of the most difficult problems to solve after thoracic surgery. Its correct control is often quite difficult, which can cause complications due to an ineffective cough and superficial respiratory movements.

Methods

This study has been designed with the purpose of studying the value of transcutaneous electrical stimulation (TENS) in the postoperative pain rehabilitation of thoracotomy. A prospective and randomized study has been developed. The patients (n = 109) have been treated after hospital discharge with physiotherapy for 3 weeks. Three groups have been established: experimental (n = 37), control (n = 35), and placebo (n = 37), experimental and placebo including the application of TENS during the physiotherapy protocol. Postoperative pain (McGill test) and spirometry have been studied before and after treatment.

Results

The largest between-group discrepancy occurred between the experimental and control groups, 16.77 points (p < 0.001). Spirometry has shown an improvement in FVC (27.11%) and FEV1 (28.68%) (p < 0.001) in the experimental group, which was statistically significant compared to the other groups.

Conclusion

The use of TENS, as an adjunctive treatment to physiotherapy, leads to an improvement in pain control and spirometry values in patients after thoracic surgery, without producing side effects with the technique. These findings provide physiological evidence for the use of TENS in post-pulmonary surgery and may form the basis for the development of pain managed-based programs in clinics and hospitals.

Trial registration

NCT04964973 (ClinicalTrials.gov). First registration: July 16, 2021.

Protocol: https://clinicaltrials.gov/study/NCT04964973.